The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
EORTC 1709/CCTG CE.8: A phase III trial of marizomib in combination with temozolomide-based radiochemotherapy versus temozolomide-based radiochemotherapy alone in patients with newly diagnosed glioblastoma.
 
Patrick Roth
Honoraria - Merck; Novocure; Roche
Consulting or Advisory Role - Bristol-Myers Squibb; Debiopharm Group; MSD; QED Therapeutics; Virometix
Research Funding - MSD (Inst); Novocure (Inst)
 
Thierry Gorlia
No Relationships to Disclose
 
Jaap C. Reijneveld
No Relationships to Disclose
 
Filip Yves Francine Leon De Vos
Research Funding - Abbvie (Inst); BioClin Therapeutics (Inst); Bristol-Myers Squibb (Inst); GlaxoSmithKline (Inst); Novartis (Inst); Octimed Oncology BV (Inst); VAXIMM (Inst)
Expert Testimony - Bristol-Myers Squibb
Travel, Accommodations, Expenses - Roche/Genentech
 
Ahmed Idbaih
Honoraria - LEO Pharma; Novocure
Consulting or Advisory Role - Health Advances
Research Funding - Air Liquide (Inst); Carthera (Inst); Nutrithéragene (Inst); Sanofi (Inst); Transgene (Inst)
Travel, Accommodations, Expenses - CarThera; LEO Pharma
 
Jean-Sebastien Frenel
Consulting or Advisory Role - Amgen; AstraZeneca; Daiichi Sankyo Europe GmbH; GlaxoSmithKline; Lilly; Novartis; Novocure; Pfizer; Pierre Fabre; Roche
Travel, Accommodations, Expenses - AstraZeneca; Daiichi Sankyo Europe GmbH; Lilly; Novartis; Pfizer; Roche
 
Emilie Le Rhun
Consulting or Advisory Role - Adastra Pharmaceuticals; Daiichi Sankyo; Leo Pharma; Seagen; Tocagen
Travel, Accommodations, Expenses - Abbvie
 
José Manuel Sepulveda Sánchez
Consulting or Advisory Role - Abbvie; Celgene; GW Pharmaceuticals; IDP Pharmaceuticals; Pfizer
Research Funding - IDP Pharmaceuticals; Pfizer
Travel, Accommodations, Expenses - Abbvie; Ipsen; Pfizer
 
James R. Perry
No Relationships to Disclose
 
Laura Masucci
Research Funding - Bristol-Myers Squibb (Inst)
 
Pierre Freres
Speakers' Bureau - Pfizer
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Hal W. Hirte
Honoraria - AstraZeneca Canada; GlaxoSmithKline; Merck
Consulting or Advisory Role - AstraZeneca Canada; Merck
 
Clemens Seidel
Honoraria - HRA Pharma; Medac
Travel, Accommodations, Expenses - Abbvie
 
Anna Maria Elisabeth Walenkamp
Research Funding - IPSEN (Inst)
Travel, Accommodations, Expenses - IPSEN (Inst)
 
Frederic Dhermain
No Relationships to Disclose
 
Martin J. Van Den Bent
Employment - AstraZeneca (I)
Consulting or Advisory Role - Abbvie; Agios; Bayer; Boehringer Ingelheim; Boston Pharmaceuticals; Bristol-Myers Squibb; carthera; Celgene; Eoche; Genenta Science; Nerviano Medical Sciences
Research Funding - Abbvie (Inst)
 
Christopher J. O'Callaghan
No Relationships to Disclose
 
Maureen Vanlancker
No Relationships to Disclose
 
Warren P. Mason
Consulting or Advisory Role - GlaxoSmithKline
 
Michael Weller
Honoraria - Adastra Pharmaceuticals; Merck Serono; MSD; Nerviano Medical Sciences; Philogen
Consulting or Advisory Role - Bristol-Myers Squibb; Karyopharm Therapeutics; Medac; Orbus Therapeutics; Tocagen; Ymabs Therapeutics Inc
Research Funding - Apogenix (Inst); Merck Serono (Inst); Merck Sharp & Dohme (Inst); Novocure (Inst); Quercegen Pharmaceuticals (Inst)